Cargando…
A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
BACKGROUND: Glioma is one of the most common malignancies in the central nervous system and has limited effective therapeutic options. Therefore, we sought to identify a suitable target for immunotherapy. MATERIALS AND METHODS: We screened prognostic genes for glioma in the CGGA database and GSE4337...
Autores principales: | Zhang, Yu, Yang, Xin, Zhu, Xiao-Lin, Wang, Zhuang-Zhuang, Bai, Hao, Zhang, Jun-Jie, Hao, Chun-Yan, Duan, Hu-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085360/ https://www.ncbi.nlm.nih.gov/pubmed/33937046 http://dx.doi.org/10.3389/fonc.2021.643159 |
Ejemplares similares
-
S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma
por: Zhang, Yu, et al.
Publicado: (2021) -
Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022) -
A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment
por: Zhang, Jun-Jie, et al.
Publicado: (2023) -
CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas
por: Liu, Liling, et al.
Publicado: (2021) -
LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)